Patient & Visitor InformationContact Us
  • Genitourinary Multidisciplinary Clinic

  • Comprehensive Services

  • The CyberKnife Robotic Radiosurgery System provides an additional option to patients diagnosed with previously inoperable or surgically complex tumors. It is a highly sophisticated radiosurgery system designed to treat tumors with sub-millimeter accuracy anywhere in the body. Read more about Cyberknife Robotic Radiosurgery

    Our clinic provides care ranging from the screening of high-risk individuals, to the most innovative treatments, including cutting-edge radiation oncology services, robotic surgery and access to investigational therapies.

    Our services include:

    • one-time consultation, evaluation and second opinions

    • screening and diagnostic tests

    • medical oncology

    • technical/surgical services

    • advanced expertise in robotic prostatectomy

    • sophisticated radiation oncology services, including CyberKnife, intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and brachytherapy

    • comprehensive complementary services, including nutrition consultation, social work, physical therapy, primary nurse and nurse practitioner, patient education resources and support groups

    • support from the genitourinary nurse navigator, a registered nurse who is trained in oncology and possesses an in-depth understanding of genitourinary cancers and the process patients undergo. The navigator guides patients through the health care system and the course of their treatment in several ways, including the coordination of services, facilitation of communication with health care professionals, arrangement of interpreters and transportation, assistance with insurance and financial questions, and education and emotional support.

    Access to Clinical Trials

    Our physicians are actively involved in a number of clinical trials at The Miriam and Rhode Island hospitals, as well as those sponsored by collaborative national groups and the National Cancer Institute.

    Consequently, eligible patients have access to many promising new therapies and contribute to research that leads to better outcomes for all patients.

    Among the areas our researchers are currently investigating:

    • Treatment for early stage prostate cancer
    • Treatment for advanced prostate cancer
    • Treatment for renal cancer after surgery

    Support Groups